COVID-19-Associated Lung Fibrosis: Two Pathways and Two Phenotypes, Lung Transplantation, and Antifibrotics
COVID-19 can be associated with lung fibrosis. Although lung fibrosis after COVID-19 is a relatively rare finding, the mere fact that globally a very large number of patients have had COVID-19 leads to a significant burden of disease. However, patients with COVID-19-associated lung fibrosis have dif...
Main Authors: | René Hage, Macé M. Schuurmans |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Transplantology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3943/3/3/24 |
Similar Items
-
Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports
by: Tiphaine Goletto, et al.
Published: (2022-01-01) -
Frailty as a Prognostic Indicator in Lung Transplantation: A Comprehensive Analysis
by: René Hage, et al.
Published: (2023-12-01) -
COVID-Related Chronic Allograft Dysfunction in Lung Transplant Recipients: Long-Term Follow-up Results from Infections Occurring in the Pre-vaccination Era
by: René Hage, et al.
Published: (2022-09-01) -
DNA Methylation of Fibroblast Phenotypes and Contributions to Lung Fibrosis
by: Poojitha Rajasekar, et al.
Published: (2021-08-01) -
Lung Transplantation in Idiopathic Pulmonary Fibrosis
by: Rosalía Laporta Hernandez, et al.
Published: (2018-08-01)